Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    AstraZeneca's Experimental Stomach Cancer Drug Doubles Survival In Late-Stage Trial

    1 day ago

    Astra has pegged potential annual sales for the treatment, whose full name is sonesitatug vedotin, at between $3 billion and $5 billion. It targets a protein found in the lining of the stomach that's expressed in some gastric cancers.
    Click here to Read More
    Previous Article
    Pune Housing Market Gives Buyers More Options As Property Prices cool, Bengaluru Jumps to 14.5%
    Next Article
    From E85 To E100: Govt Amends Rules To Make Room For 100% Ethanol Vehicles

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment